Physician profile
Dharmendrakumar A Patel
NPI 1427248756
$7,152.61
in general payments reported to CMS, 2019-2025
39 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $412 · 2021: $253 · 2022: $1,264 · 2023: $1,694 · 2024: $1,076 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,035 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,034.83 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,144.95 | 2019-2025 | |
| Abiomed | $1,019.72 | 2022-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $500.77 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $470.93 | 2019-2025 | |
| Boston Scientific Corporation | $379.98 | 2019-2025 | Watchman Flx, Watchman Access System |
| Atricure, INC. | $369.07 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.90 | 2020-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $319.32 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $292.99 | 2021-2025 | Lifevest |
| Amgen INC. | $232.54 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $220.94 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $184.75 | 2019-2023 | Farxiga, Wainua |
| Kestra Medical Technology Services, INC. | $156.73 | 2025 | Assure Wcd |
| Medical Device Business Services, INC. | $153.23 | 2023 | Monocryl |
| Inari Medical, INC. | $144.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $143.59 | 2025 | Flowtriever |
| Sanofi-Aventis U.S. LLC | $136.81 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $132.75 | 2022-2023 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $130.85 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $72.82 | 2022-2025 | |
| Novo Nordisk INC | $58.01 | 2023 | Ozempic, Rybelsus |
| Medtronic, INC. | $57.24 | 2025 | Aurora Ev-Icd Mri Surescan |
| Astellas Pharma US INC | $56.16 | 2019 | |
| Abbott Laboratories | $49.90 | 2022-2024 | Amplatzer Amulet |
| Baxter Healthcare | $45.59 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $42.27 | 2024 | |
| Merck Sharp & Dohme LLC | $37.07 | 2024 | Verquvo |
| Arbor Pharmaceuticals, INC. | $36.82 | 2019 | |
| Alnylam Pharmaceuticals INC. | $30.42 | 2019-2020 | |
| Lundbeck LLC | $29.82 | 2019 | |
| Akcea Therapeutics, INC. | $26.90 | 2019-2020 | |
| Cvrx, INC. | $26.53 | 2024 | Barostim Neo System |
| Scpharmaceuticals INC. | $20.90 | 2024 | |
| Amarin Pharma, INC. | $18.11 | 2020 | |
| Biosense Webster, INC. | $17.71 | 2024 | Nuvision Ice Catheter |
| Gilead Sciences, INC. | $15.27 | 2019 | |
| Philips North America LLC | $13.79 | 2025 | Icap Bundled With Eici |
| Regeneron Healthcare Solutions, INC. | $13.11 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharmendrakumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.